{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:20:35Z","timestamp":1777558835317,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81600691"],"award-info":[{"award-number":["81600691"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Postdoctoral Science Foundation funded project","award":["2018M640615"],"award-info":[{"award-number":["2018M640615"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gitelman syndrome is a rare salt-losing renal tubular disorder associated with mutation of\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      gene, which encodes the Na-Cl co-transporter (NCCT). Gitelman syndrome is characterized by hypokalemia, metabolic alkalosis, hypomagnesemia, hypocalciuria, and renin-angiotensin-aldosterone system (RAAS) activation. Different\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      variants may lead to phenotypic variability and severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we reported the clinical features and genetic analysis of a Chinese pedigree diagnosed with Gitelman syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The proband exhibited hypokalaemia, hypomagnesemia, metabolic alkalosis, but hypercalciuria and kidney stone formation. The increased urinary calcium excretion made it confused to Bartter syndrome. The persistent renal potassium wasting resulted in renal tubular lesions, and might affect urinary calcium reabsorption and excretion. Genetic analysis revealed mutations of\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      gene with c.433C\u2009&gt;\u2009T (p.Arg145Cys), c.1077C\u2009&gt;\u2009G (p.Asn359Lys), and c.1666C\u2009&gt;\u2009T (p.Pro556Ser). Potential alterations of structure and function of NCCT protein due to those genetic variations of\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      are predicted. Interestingly, one sibling of the proband carried the same mutant sites and exhibited similar clinical features with milder phenotypes of hypokalemia and hypomagnesemia, but hypocalciuria rather than hypercalciuria. Family members with at least one wild type copy of\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      had normal biochemistry. With administration of spironolactone, potassium chloride and magnesium supplement, the serum potassium and magnesium were maintained within normal ranges.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this study, we identified compound mutations of\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      associated with varieties of clinical features. Further efforts are needed to investigate the diversity in clinical manifestations of Gitelman syndrome and its correlation with specific\n                      <jats:italic>SLC12A3<\/jats:italic>\n                      mutations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01996-2","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T07:02:58Z","timestamp":1596610978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes"],"prefix":"10.1186","volume":"21","author":[{"given":"Bingzi","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"issue":"3","key":"1996_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-3-22","volume":"30","author":"NV Knoers","year":"2008","unstructured":"Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008;30(3):22.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"1996_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00467-006-0321-1","volume":"22","author":"E Riveira-Munoz","year":"2007","unstructured":"Riveira-Munoz E, Chang Q, Bindels RJ, Devuyst O. Gitelman's syndrome: towards genotype-phenotype correlations? Pediatr Nephrol. 2007;22(3):326\u201332.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1681\/ASN.2006101095","volume":"18","author":"E Riveira-Munoz","year":"2007","unstructured":"Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18(4):1271\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1996_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1440-1797.2008.01042.x","volume":"14","author":"L Qin","year":"2009","unstructured":"Qin L, Shao L, Ren H, et al. Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome. Nephrology. 2009;14(1):52\u20138.","journal-title":"Nephrology."},{"issue":"6","key":"1996_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11655-016-2461-x","volume":"23","author":"JW Luo","year":"2017","unstructured":"Luo JW, Meng XR, Yang X, et al. Analysis of mutations of two Gitelman syndrome family SLC12A3 genes and proposed treatments using Chinese medicine. Chin J Integr Med. 2017;23(6):461\u20138.","journal-title":"Chin J Integr Med"},{"issue":"6","key":"1996_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/cen.12820","volume":"83","author":"C Li","year":"2015","unstructured":"Li C, Zhou X, Han W, et al. Identification of two novel mutations in SLC12A3 gene in two Chinese pedigrees with Gitelman syndrome and review of literature. Clin Endocrinol. 2015;83(6):985\u201393.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1996_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12020-011-9556-0","volume":"41","author":"F Nakhoul","year":"2012","unstructured":"Nakhoul F, Nakhoul N, Dorman E, Berger L, Skorecki K, Magen D. Gitelman's syndrome: a pathophysiological and clinical update. Endocrine. 2012;41(1):53\u20137.","journal-title":"Endocrine."},{"issue":"1","key":"1996_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0022-3476(05)80594-3","volume":"120","author":"A Bettinelli","year":"1992","unstructured":"Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120(1):38\u201343.","journal-title":"J Pediatr"},{"issue":"2","key":"1996_CR9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1046\/j.1523-1755.2001.059002710.x","volume":"59","author":"DN Cruz","year":"2001","unstructured":"Cruz DN, Shaer AJ, Bia MJ, Lifton RP. Simon DB; Yale Gitelman\u2019s and Bartter\u2019s syndrome collaborative study group. Gitelman\u2019s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59(2):710\u20137.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"1996_CR10","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.3345\/kjp.2016.59.11.S103","volume":"59","author":"HW Cho","year":"2016","unstructured":"Cho HW, Lee ST, Cho H, Cheong HI. A novel mutation of CLCNKB in a Korean patient of mixed phenotype of Bartter-Gitelman syndrome. Korean J Pediatr. 2016;59(Suppl 1):S103\u20136.","journal-title":"Korean J Pediatr"},{"issue":"4","key":"1996_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-11-0224","volume":"165","author":"AS Balavoine","year":"2011","unstructured":"Balavoine AS, Bataille P, Vanhille P, et al. Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome. Eur J Endocrinol. 2011;165(4):665\u201373.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1996_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ng0696-183","volume":"13","author":"DB Simon","year":"1996","unstructured":"Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter\u2019s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13(2):183\u20138.","journal-title":"Nat Genet"},{"issue":"6","key":"1996_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00000441-200112000-00004","volume":"322","author":"AJ Shaer","year":"2001","unstructured":"Shaer AJ. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Am J Med Sci. 2001;322(6):316\u201332.","journal-title":"Am J Med Sci"},{"issue":"1","key":"1996_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12519-012-0333-9","volume":"8","author":"OT Fremont","year":"2012","unstructured":"Fremont OT, Chan JC. Understanding Bartter syndrome and Gitelman syndrome. 2012. World J Pediatr. 2012;8(1):25\u201330.","journal-title":"World J Pediatr"},{"issue":"2","key":"1996_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/gim.2015.56","volume":"18","author":"N Matsunoshita","year":"2016","unstructured":"Matsunoshita N, Nozu K, Shono A, et al. Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter\/Gitelman syndrome based on clinical characteristics. Genet Med. 2016;18(2):180\u20138.","journal-title":"Genet Med"},{"issue":"4","key":"1996_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/0971-4065.83748","volume":"21","author":"RP Goswami","year":"2011","unstructured":"Goswami RP, Mandal S, Karmakar PS, Ghosh A. Diuretic loading test and use of Bartter's Normogram in diagnosing a case of Gitelman's syndrome: relook into pathophysiology. Indian J Nephrol. 2011;21(4):289\u201392.","journal-title":"Indian J Nephrol"},{"issue":"6","key":"1996_CR17","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI24134","volume":"115","author":"T Nijenhuis","year":"2005","unstructured":"Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115(6):1651\u20138.","journal-title":"J Clin Invest"},{"issue":"8","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"E1478","DOI":"10.1210\/jc.2012-1707","volume":"97","author":"MH Tseng","year":"2012","unstructured":"Tseng MH, Yang SS, Hsu YJ, et al. Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation. J Clin Endocrinol Metab. 2012;97(8):E1478\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1996_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jbmr.2306","volume":"30","author":"YJ Hsu","year":"2015","unstructured":"Hsu YJ, Yang SS, Cheng CJ, et al. Thiazide-sensitive Na+\u2212cl\u2212 Cotransporter (NCC) gene inactivation results in increased duodenal Ca2+ absorption, enhanced osteoblast differentiation and elevated bone mineral density. J Bone Miner Res. 2015;30(1):116\u201327.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000346708","volume":"37","author":"H Ren","year":"2013","unstructured":"Ren H, Qin L, Wang W, et al. Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome. Am J Nephrol. 2013;37(2):152\u20137.","journal-title":"Am J Nephrol"},{"issue":"9","key":"1996_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.tem.2009.05.006","volume":"20","author":"MC Zennaro","year":"2009","unstructured":"Zennaro MC, Caprio M, F\u00e8ve B. Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol Metab. 2009;20(9):444\u201351.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1996_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cen.12829","volume":"84","author":"T Mizokami","year":"2016","unstructured":"Mizokami T, Hishinuma A, Kogai T, et al. Graves' disease and Gitelman syndrome. Clin Endocrinol. 2016;84(1):149\u201350.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1996_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1053\/j.ajkd.2008.07.025","volume":"52","author":"YK Kim","year":"2008","unstructured":"Kim YK, Song HC, Kim WY, et al. Acquired Gitelman syndrome in a patient with primary Sj\u00f6gren syndrome. Am J Kidney Dis. 2008;52(6):1163\u20137.","journal-title":"Am J Kidney Dis"},{"key":"1996_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000360773","volume":"39","author":"L Jiang","year":"2014","unstructured":"Jiang L, Chen C, Yuan T, et al. Clinical severity of Gitelman syndrome determined by serum magnesium. Am J Nephrol. 2014;39:357\u201366.","journal-title":"Am J Nephrol"},{"issue":"10","key":"1996_CR25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00467-011-1871-4","volume":"26","author":"HW Seyberth","year":"2011","unstructured":"Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol. 2011;26(10):1789\u2013802.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1996_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1681\/ASN.2014030293","volume":"26","author":"A Blanchard","year":"2015","unstructured":"Blanchard A, Vargas-Poussou R, Vallet M, et al. Indomethacin, Amiloride, or Eplerenone for treating hypokalemia in Gitelman syndrome. J Am Soc Nephrol. 2015;26(2):468\u201375.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01996-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01996-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01996-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:40:01Z","timestamp":1628106001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01996-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01996-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-20998\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"21 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Affiliated Hospital of Qingdao University with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. We obtained the written informed consent from all the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The clinical data, including age and sex of participants, and images were obtained from the proband and his family members. All the participants gave their written consent for the information to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}